Edition:
United States

DexCom Inc (DXCM.OQ)

DXCM.OQ on NASDAQ Stock Exchange Global Select Market

62.49USD
11:29am EST
Change (% chg)

$-2.99 (-4.57%)
Prev Close
$65.48
Open
$65.00
Day's High
$65.22
Day's Low
$62.41
Volume
78,557
Avg. Vol
339,777
52-wk High
$96.27
52-wk Low
$48.00

DXCM.OQ

Chart for DXCM.OQ

About

Dexcom, Inc. (Dexcom) is a medical device company. The Company is focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers for the treatment of people with and without diabetes. Its products include SEVEN PLUS,... (more)

Overall

Beta: 0.52
Market Cap(Mil.): $5,534.64
Shares Outstanding(Mil.): 84.52
Dividend: --
Yield (%): --

Financials

  DXCM.OQ Industry Sector
P/E (TTM): -- 31.03 30.77
EPS (TTM): -0.68 -- --
ROI: -23.94 13.42 15.23
ROE: -24.92 17.11 16.56

BRIEF-DexCom Q3 GAAP loss per share $0.22

* Q3 revenue $148.6 million versus I/B/E/S view $146.3 million

Nov 01 2016

BRIEF-Dexcom Inc Reports second quarter 2016 financial results

* Q2 revenue $137.3 million versus I/B/E/S view $132.6 million

Aug 02 2016

BRIEF-Dexcom- FDA votes for Dexcom G5 Mobile CGM System non-adjunctive label

* FDA advisory committee votes in favor of non-adjunctive label for Dexcom G5 Mobile CGM System

Jul 22 2016

BRIEF-Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting

* Dexcom Inc says FDA posts briefing documents ahead of advisory committee meeting

Jul 19 2016

Competitors

  Price Chg
Roche Holding Ltd. (ROG.S) CHF221.20 -2.30
Roche Holding Ltd. (RO.S) CHF225.20 -3.00
Johnson & Johnson (JNJ.N) $109.99 -2.07
Abbott Laboratories (ABT.N) $38.10 -0.31
Medtronic PLC (MDT.N) $71.97 -0.14

Earnings vs. Estimates